Pricing Log in Create free account

CervoMed Inc. (CRVO) vs LianBio Sponsored ADR (LIANY)

CervoMed Inc. and LianBio Sponsored ADR are both Biotechnology companies. CervoMed Inc. and LianBio Sponsored ADR are of similar size ($34.2M and $34.0M). CervoMed Inc. has negative trailing earnings, so its P/E is not meaningful; LianBio Sponsored ADR trades at 0.0×. Across the 10 metrics below, LianBio Sponsored ADR leads on 7 and CervoMed Inc. on 3.

Valuation

Metric CRVO LIANY Biotechnology median
P/E n/m 0.02 8.50
P/S 5.73 n/m 9.71
P/B 1.00 0.01 2.13
Price to free cash flow n/m 0.02 20.82
EV/EBITDA n/m 5.72 0.64
EV/Sales 2.74 n/m 9.21
Earnings yield (143.75%) 5,773.40% (33.15%)
Free cash flow yield (123.82%) 4,795.89% (25.50%)

Profitability

Metric CRVO LIANY Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (107.62%) 70.96% (56.36%)
Return on assets (94.73%) 66.19% (48.04%)
Return on invested capital 0.00% (450.47%) 0.00%

Growth

Metric CRVO LIANY Biotechnology median
Revenue growth (TTM) (58.86%) — 6.02%
EPS growth (last fiscal year) (47.52%) 75.44% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRVO LIANY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.57 17.03 4.72
Net debt to EBITDA 0.74 7.41 0.96

Dividend

Metric CRVO LIANY Biotechnology median
Dividend yield — 0.00% 0.09%
Payout ratio — — —

Size

Metric CRVO LIANY Biotechnology median
Market cap 34.02m 34.19m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack